The Pricing Shock: How the Inflation Reduction Act Rewrites the Valuation Rules The economic foundations of the pharmaceutical industry are […]

Direct-to-consumer (DTC) pharmaceutical companies are no longer just apps for convenience. Hims & Hers and Ro have spent the last

The economics of the leaky bucket In the pharmaceutical business, time is the only currency that truly matters. Inventors often

The Ticking Clock: Why Patent Expiration is the Most Important Date in Pharma In pharmaceutical finance and strategy, a single

The era of easy arbitrage is over. If you have spent the last three years running a 503B outsourcing facility,

The Crucible of Market Dominance: A Paradigm Shift In pharmaceutical and biotechnology innovation patent litigation is not a mere legal

The rules of pharmaceutical competition in Europe are no longer a matter of simple patent filing and clinical success. By

The pharmaceutical industry operates at the confluence of high-stakes molecular innovation and rigorous intellectual property fortification. Among the most sophisticated

The pharmaceutical supply chain remains a largely invisible mechanism until the moment it ceases to function. Much like a Victorian